Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.
Saved in:
| Title: | Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study. |
|---|---|
| Authors: | Singer MA; Medical Center Ophthalmology Associates, San Antonio, Texas; University of Texas Health Science Center, San Antonio, Texas. Electronic address: msinger11@me.com., Wykoff CC; Retina Consultants of Texas, Houston, Texas., Riemann CD; Cincinnati Eye Institute, Cincinnati, Ohio; Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio., Gonzalez VH; Valley Retina Institute, McAllen, Texas., Weng CY; Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas., Alkhatib K; ANI Pharmaceuticals, Inc., Baudette, Minnesota., Amarshi RA; ANI Pharmaceuticals, Inc., Baudette, Minnesota., Moody S; ANI Pharmaceuticals, Inc., Baudette, Minnesota., Pao M; ANI Pharmaceuticals, Inc., Baudette, Minnesota. |
| Source: | Ophthalmology [Ophthalmology] 2026 Jul; Vol. 133 (7), pp. 837-851. Date of Electronic Publication: 2026 Mar 25. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase IV |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1549-4713 |
|---|---|
| DOI: | 10.1016/j.ophtha.2026.03.019 |
